Status of Metastatic Bladder Cancer Treatment Illustrated by a Case.


Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 11 1 2021
medline: 23 11 2021
entrez: 10 1 2021
Statut: ppublish

Résumé

This study aims to provide an overview of current treatment guidelines within the context of metastatic bladder cancer illustrated by a case report. International guidelines from The American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and scientific references supporting these clinical guidelines. To illustrate the implementation of current evidence-based guidelines a patient case report was presented. Historically, there have been limited treatment options available for metastatic bladder cancer for three decades. However, with the introduction of immunotherapy and emergent targeted therapies for metastatic bladder cancer increasing survival rates are expected. To achieve improved treatment outcome in people affected by metastatic bladder cancer it is important that both doctors and nurses are aware of contemporary evidence-based treatment options in keeping with ESMO and ASCO international clinical guidelines. Nurses play an important role in educating patients about the potential side effects of therapy and in offering timely, tailored, and supported self-management.

Identifiants

pubmed: 33422366
pii: S0749-2081(20)30128-5
doi: 10.1016/j.soncn.2020.151113
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151113

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Line Hammer Dohn (LH)

Department of Oncology, Herlev Gentofte Hospital, Herlev, Denmark.

Lise Høj Omland (LH)

Department of Oncology, Rigshospitalet, Copenhagen, Denmark.

Dag Rune Stormoen (DR)

Department of Oncology, Rigshospitalet, Copenhagen, Denmark.

Helle Pappot (H)

Department of Oncology, Rigshospitalet, Copenhagen, Denmark. Electronic address: helle.pappot@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH